Association of C-reactive protein with type 2 diabetes: Prospective analysis and meta-analysis

Diabetologia

Volumn 52, Issue 6, 2009, Pages 1040-1047

  Lee, C C ^a   Adler, A I ^a   Sandhu, M S ^a   Sharp, S J ^a   Forouhi, N G ^a   Erqou, S ^b   Luben, R ^b   Bingham, S ^b   Khaw, K T ^b   Wareham, N J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

C reactive protein; Meta analysis; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; INCIDENCE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 67349231934     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-009-1338-3     Document Type: Article

References (41)

1. JC Pickup MA Crook 1998 Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41 1241 1248 (Pubitemid 28449093)
2. TA Pearson GA Mensah RW Alexander 2003 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 499 511 (Pubitemid 36158056)
3. A Dehghan I Kardys MPM de Matt 2007 Genetic variation, C-reactive protein levels, and incidence of diabetes Diabetes 56 872 878 (Pubitemid 46348467)
4. Y Doi Y Kiyohara M Kubo 2005 Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population Diabetes Care 28 2497 2500 (Pubitemid 41384300)
5. DE Laaksonen L Niskanen K Nyyssonen 2004 C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men Diabetologia 47 1403 1410 (Pubitemid 39232426)
6. FB Hu JB Meigs TY Li N Rifai JE Manson 2004 Inflammatory markers and risk of developing type 2 diabetes in women Diabetes 53 693 700 (Pubitemid 38270639)
7. S Nakanishi K Yamane N Kamei M Okubo N Kohno 2003 Elevated C-reactive protein is risk factor for the development of type 2 diabetes in Japanese American Diabetes Care 26 2754 2757 (Pubitemid 37205542)
8. J Spranger A Kroke M Mohlig 2003 Inflammatory cytokines and the risk to develop type 2 diabetes Diabetes 52 812 817
9. DJ Freeman J Norrie MJ Caslake 2002 C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 51 1596 1600
10. JI Barzilay L Abraham SR Heckbert 2001 The relation of markers of inflammation to the development of glucose disorders in the elderly. The Cardiovascular Health Study Diabetes 50 2384 2389 (Pubitemid 33641926)
11. AD Pradhan JE Manson N Rifai JE Buring PM Ridker 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327 334 (Pubitemid 32656163)
12. B Thorand H Lowel A Schneider 2003 C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men Arch Intern Med 163 93 99
13. BB Duncan MI Schmidt JS Pankow 2003 Low-grade systemic inflammation and the development of type 2 diabetes. The Atherosclerosis Risk in Communities Study Diabetes 52 1799 1805 (Pubitemid 36792473)
14. A Festa R D'Agostino RP Tracy SM Haffner 2002 Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes Diabetes 51 1131 1137
15. J Krakoff T Funahashi CDA Stehouwer 2003 Inflammatory markers, adiponectin and risk of type 2 diabetes in the Pima Indian Diabetes Care 26 1745 1751 (Pubitemid 36929114)
16. TS Han N Sattar K Williams C Gonzalez-Villalpando MEJ Lean SM Haffner 2002 Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study Diabetes Care 25 2016 2021 (Pubitemid 41071061)
17. M Snijder JM Dekker M Visser 2003 Prospective relation of C-reactive protein with type 2 diabetes Diabetes Care 26 1656 1657
18. B Thorand J Baumert H Kolb 2007 Sex differences in the prediction of type 2 diabetes by inflammatory markers. Result from the MONICA/KORA Augsburg case-cohort study, 1984-2002 Diabetes Care 30 854 860 (Pubitemid 46556577)
19. RS Lindsay T Funahashi RL Hanson 2002 Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 57 58 (Pubitemid 34756495)
20. J Spranger A Kroke M Mohlig 2003 Adiponectin and protection against type 2 diabetes mellitus Lancet 361 226 228 (Pubitemid 36126226)
21. BB Duncan MI Schmidt JS Pankow 2004 Adiponectin and the development of type 2 diabetes Diabetes 53 2473 2478
22. DH Lee K Silventoinen DR Jacobs Jr P Jousilahti J Tuomileto 2004 Gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women J Clin Endocrinol Metab 89 5410 5414 (Pubitemid 39518418)
23. M Nannipieri C Gonzales S Baldi 2005 Liver enzymes, the metabolic syndrome and incident diabetes: the Mexico City Diabetes Study Diabetes Care 28 1757 1762 (Pubitemid 40923089)
24. P Andre B Balkau C Born MA Charles E Eschwege 2006 Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the DESIR cohort Diabetologia 49 2599 2603
25. MB Schulze EB Rimm I Shai N Rifai FB Hu 2004 Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes Diabetes Care 27 1680 1687 (Pubitemid 38857444)
26. DH Lee DR Jacobs Jr 2005 Association between serum gamma- glutamyltransferase and C-reactive protein Atherosclerosis 178 327 330 (Pubitemid 40193447)
27. N Day S Oakes R Luben 1999 EPIC-Norfolk: study design, characteristics of the cohort. European Prospective Investigation of Cancer Br J Cancer 80 Suppl 1 95 103
28. AH Harding NE Day KT Khaw 2004 Dietary fat and the risk of clinical type 2 diabetes: the European Prospective of Cancer-Norfolk Study Am J Epidemiol 159 73 82 (Pubitemid 38049424)
29. NG Forouhi AH Harding M Allison 2007 Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study Diabetologia 50 949 956 (Pubitemid 46559245)
30. J Danesh R Collins P Appleby R Peto 1998 Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analysis of prospective studies JAMA 279 1477 1482 (Pubitemid 28228207)
31. JP Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analysis BMJ 327 557 560
32. M Yoneda H Mawatari K Fujita 2007 High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH J Gastroenterol 42 573 582 (Pubitemid 47190075)
33. AO Rantala M Lilja H Kauma MJ Savolainen A Reunanen YA Kesaniemi 2000 Gamma-glutamyl transpeptidase and the metabolic syndrome J Intern Med 248 230 238
34. YH Kang HK Min SM Son IJ Kim YK Kim 2007 The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults Diabetes Res Clin Pract 77 306 313 (Pubitemid 46670410)
35. H Sakugawa T Nakayoshi K Kobashigawa 2004 Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women World J Gastroenterol 10 1052 1055 (Pubitemid 38461393)
36. G Yuan X Chen Q Ma 2007 C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes J Endocrinol 194 275 281 (Pubitemid 47249666)
37. O Hamdy S Porramatikul E Al-Ozairi 2006 Metabolic obesity: the paradox between visceral and subcutaneous fat Curr Diabetes Rev 2 367 373
38. JR Greenfield K Samaras AB Jenkins 2004 Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences Circulation 109 3022 3028 (Pubitemid 38808325)
39. PJ Manning WH Sutherland AR Allum SA de Jong SD Jones 2002 Effect of hormone replacement therapy on inflammation-sensitive proteins in post-menopausal women with type 2 diabetes Diabet Med 19 847 852 (Pubitemid 35177185)
40. HK Meier-Ewert PM Ridker N Rifai 2001 Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects Clin Chem 47 426 430 (Pubitemid 32222455)
41. J Danesh JG Wheeler GM Hirschfield 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 1387 1397 (Pubitemid 38419992)